(Q52247619)

English

Mining the National Cancer Institute Anticancer Drug Discovery Database: Cluster Analysis of Ellipticine Analogs with p53-Inverse and Central Nervous System-Selective Patterns of Activity

scientific article published on February 1, 1998

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/9463482

Mining the National Cancer Institute Anticancer Drug Discovery Database: Cluster Analysis of Ellipticine Analogs with p53-Inverse and Central Nervous System-Selective Patterns of Activity (English)

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

cluster analysis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9463482

6 December 2024

National Institutes of Health

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9463482

6 December 2024

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9463482

6 December 2024

6

object named as

Friend SH

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/9463482

Timothy G Myers

2

object named as

T. G. Myers

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9463482

6 December 2024

John N Weinstein

7

object named as

J. N. Weinstein

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9463482

6 December 2024

author name string

L. M. Shi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9463482

6 December 2024

Y. Fan

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9463482

6 December 2024

P. M. O'Connor

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9463482

6 December 2024

K. D. Paull

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9463482

6 December 2024

S. H. Friend

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9463482

6 December 2024

publication date

1 February 1998

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/9463482

February 1998

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9463482

6 December 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9463482

6 December 2024

full work available at URL

http://molpharm.aspetjournals.org/cgi/content/abstract/53/2/241

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9463482

6 December 2024

https://syndication.highwire.org/content/doi/10.1124/mol.53.2.241

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

Molecular Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/9463482

53

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/9463482

2

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/9463482

241-251

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/9463482

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/JNCI/83.11.757

Anticancer specificity of some ellipticinium salts against human brain tumors in vitro

1

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

Design, synthesis, and study of 9-substituted ellipticine and 2-methylellipticinium analogues as potential CNS-selective antitumor agents

2

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

Molecular targets in the National Cancer Institute drug screen

3

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

Design, synthesis, and biological evaluation of ellipticine-estradiol conjugates

7

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard

9

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline.

11

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

Alkaloids of Ochrosia elliptica Labill.1

12

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

p53 tumor suppressor gene: from the basic research laboratory to the clinic--an abridged historical perspective

14

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

p53 mutations in human cancers

15

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

Design and synthesis of ellipticinium salts and 1,2-dihydroellipticines with high selectivities against human CNS cancers in vitro

16

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

Uptake and cytotoxicity of 9-methoxy-N2-methylellipticinium acetate in human brain and non-brain tumor cell lines

17

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

Quantitative Structure-Activity Relationship of Multidrug Resistance Reversal Agents

18

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

Intercalative binding of ellipticine to DNA

19

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

Discrimination techniques applied to the NCI in vitro anti-tumour drug screen: predicting biochemical mechanism of action

21

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

Rapid mass spectrometric identification of proteins from two-dimensional polyacrylamide gels after in gel proteolytic digestion.

22

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

100 and 50 years ago

23

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

National Cancer Institute Drug Information System 3D database.

24

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

A protein expression database for the molecular pharmacology of cancer

26

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm

29

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

Application of Genetic Function Approximation to Quantitative Structure-Activity Relationships and Quantitative Structure-Property Relationships

30

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

Mining the NCI Anticancer Drug Discovery Databases: Genetic Function Approximation for the QSAR Study of Anticancer Ellipticine Analogues

34

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

Structure-activity relationship study on N-glycosyl moieties through model building of DNA and ellipticine N-glycoside complex

35

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

Use of the Kohonen self-organizing map to study the mechanisms of action of chemotherapeutic agents

36

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

Phenytoin prodrugs III: water-soluble prodrugs for oral and/or parenteral use

37

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

Cellular uptake as a determinant of cytotoxicity of quaternized ellipticines to human brain tumor cells

38

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

Neural computing in cancer drug development: predicting mechanism of action

39

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

An information-intensive approach to the molecular pharmacology of cancer.

40

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

Predictive statistics and artificial intelligence in the U.S. National Cancer Institute's Drug Discovery Program for Cancer and AIDS.

41

1 reference

10.1124/MOL.53.2.241

https://api.crossref.org/works/10.1124/MOL.53.2.241

6 December 2024

Identifiers

10.1124/MOL.53.2.241

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/9463482

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 April 2018

http://europepmc.org/abstract/MED/9463482

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52247619&oldid=2284093092"